Drug
Csl362
Csl362: highest development phase Phase 1, developed by CSL. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- CSL
Trials
| Drug | Phase | Indication |
|---|---|---|
| CSL362 NCT01632852 | Phase 1 | Leukemia, Myeloid, Acute |
Latest
No recent events.
Follow Csl362 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.